nfkb retweeted
La résignation n'est pas une option. Face aux difficultés de notre pays, l'heure est venue de prendre ses responsabilités.
Je suis candidat à l'élection présidentielle de 2027.
#TeddyRiner2027 #Présidentielle2027 #LaFrancequonveut
nfkb retweeted
Crowdsourcing this ECG that a colleague sent me.
I don't know much history other than there has been no heart surgery and no dig use
RR intervals are stable
(I have never seen such a thing.)
nfkb retweeted
Is it just me or are lower protein targets trending among muscle builders? This guy has 7.3 million YouTube followers.
youtu.be/j1bx0GMofYw
nfkb retweeted
Effect of Lipid Lowering Therapies on Lp(a)
1️⃣ CETPi: −45.99% (−6.77 mg/dL)
2️⃣ Niacin: −37.14% (−7.06 mg/dL)
3️⃣ PCSK9 mAbs: −28.64% (−6.37 mg/dL)
4️⃣ Inclisiran: −21.73% (−4.76 mg/dL)
5️⃣ Fibrates: −2.30% (−0.61 mg/dL)
6️⃣ Omega-3 FAs: −2.09% (−0.28 mg/dL)
7️⃣ Statins: −0.89% (−0.19 mg/dL)
8️⃣ Ezetimibe: −0.81% (−0.21 mg/dL)
9️⃣ Bempedoic acid: +0.06% (+0.01 mg/dL)
@DrKarlNadolsky @drmatthewnagra @DrNadolsky @NutritionMadeS3 @maciejbanach
atherosclerosis-journal.com/…
nfkb retweeted
Exercise and Atrial Fibrillation
1️⃣ Exercise has both protective and adverse effects on AF.
2️⃣ AF risk shows a U-shaped link with exercise intensity.
3️⃣ Moderate exercise lowers AF burden by improving heart health and reducing fibrosis.
4️⃣ Excessive endurance training may raise AF risk, especially in young athletes.
5️⃣ Guidelines recommend moderate aerobic activity as the best approach for AF.
@NutritionMadeS3 @DrKarlNadolsky @DrNadolsky
imrpress.com/journal/RCM/26/…
nfkb retweeted
Pitavastatin is unique among statins - lowest risk of diabetes (actually improves blood glucose in some studies) and least likely to cause muscle pain
nfkb retweeted
📢 Une décision qui interroge sur l'avenir de la transparence en santé
Hier, plusieurs membres de notre collectif ont été sanctionnés par la Chambre Disciplinaire Nationale de l'Ordre des Médecins pour leurs prises de position publiques sur l'homéopathie.
nfkb retweeted
Perioperative management of renin–angiotensin system inhibitors in patients undergoing elective major noncardiac surgery: a mixed model investigation using systematic review, meta-analysis, multicentre service evaluation, and national survey bjanaesthesia.org/article/S0…
nfkb retweeted
When investing in a company you don't run, imagine a someone from that company investing in your business. You will immediately see him as a sucker, easy to fool because of the asymmetry of the information.
When you invest, you are the sucker & you don't know where.
nfkb retweeted
90 grammes / heure pendant les étapes de montagne pour Pogacar. La révolution des glucides à 120 g/h c'est pas pour lui.
nfkb retweeted
Take a look at a rare case of spontaneous ureteral dissection induced by weight lifting. #ImagesInRadiology bit.ly/4eR5uZ3
nfkb retweeted
Private Equity is engaged in buying artisanal semi-businesses, turning them into businesses, propping up the numbers while destroying them —then, hopefully, destroying itself.
nfkb retweeted
Who knew AFib is mainly a lifestyle disease, like diabetes — and more common than cancer? 🤨
I crashed the home of the most interesting man in the (AFib) world, and this happened:
youtu.be/jW0uxwNkHPQ
nfkb retweeted
After 21 years at my dream job, I’m very sad to announce my early retirement from the National Institutes of Health. My life’s work has been to scientifically study how our food environment affects what we eat, and how what we eat affects our physiology. Lately, I’ve focused on unravelling the reasons why diets high in ultra-processed food are linked to epidemic proportions of chronic diseases such as diabetes and obesity. Our research leads the world on this topic.
Given recent bipartisan goals to prevent diet-related chronic diseases, and new agency leadership professing to prioritize scientific investigation of ultra-processed foods, I had hoped to expand our research program with ambitious plans to more rapidly and efficiently determine how our food is likely making Americans chronically sick.
Unfortunately, recent events have made me question whether NIH continues to be a place where I can freely conduct unbiased science. Specifically, I experienced censorship in the reporting of our research because of agency concerns that it did not appear to fully support preconceived narratives of my agency’s leadership about ultra-processed food addiction.
I was hoping this was an aberration. So, weeks ago I wrote to my agency’s leadership expressing my concerns and requested time to discuss these issues, but I never received a response. Without any reassurance there wouldn’t be continued censorship or meddling in our research, I felt compelled to accept early retirement to preserve health insurance for my family. (Resigning later in protest of any future meddling or censorship would result in losing that benefit.) Due to very tight deadlines to make this decision, I don’t yet have plans for my future career.
The NIH has been a wonderful place because it allows scientists to take risks, form unique collaborations, and do studies difficult to conduct elsewhere. I’m proud of what we’ve accomplished and I’m fortunate to have had such wonderful colleagues and scientific collaborators. I hope to someday return to government service and lead a research program that will continue to provide gold-standard science to make Americans healthy.






























